Latest AI and machine learning research in hematology for healthcare professionals.
BACKGROUND AND OBJECTIVES: Deep learning-based systems have shown promise in automating white blood ...
Melanoma is an aggressive skin malignancy characterized by high metastatic potential and resistance ...
OBJECTIVE: Dual-energy contrast-enhanced digital breast tomosynthesis (DECE-DBT) could provide the q...
BACKGROUND: Type 2 diabetes is a widespread chronic condition in which blood glucose and body weight...
OBJECTIVE: We developed and validated interpretable machine learning models predicting successful we...
OBJECTIVES: Chronic high-altitude hypoxia induces adaptive erythrocytosis, but the relationship betw...
BACKGROUND: Hypertension remains a major contributor to stroke burden; however, conventional blood p...
OBJECTIVE: This study aimed to develop a predictive model for left atrial appendage thrombus (LAAT) ...
BACKGROUND: In aspirin-treated unstable angina (UA), heterogeneity in on-treatment arachidonic acid ...
Hematological malignancies represent a growing global health burden, with conventional therapies lim...
BACKGROUND: Low- and middle-income countries (LMICs), particularly Sub-Saharan Africa, experience a ...
OBJECTIVES: Methotrexate (MTX) is the first-line treatment for rheumatoid arthritis (RA), yet inadeq...
BACKGROUND: Subjective, inconsistent clinician judgement on red blood cell (RBC) transfusion demand ...
This study presents a novel computational framework for nanoparticle-assisted drug delivery in abdom...
PURPOSE: While an association between trastuzumab emtansine (T-DM1) and development of portal hypert...
CONTEXT: Pathological thrombosis is a major cause of cardiovascular and cerebrovascular diseases. Cu...
Advances in the treatment of thalassaemia have led to major improvements in survival and quality of ...
ETHNOPHARMACOLOGICAL RELEVANCE: Danggui Buxue Tang (DBT), a classical Chinese herbal formula of Astr...
INTRODUCTION: We sought to clarify the interference of red blood cell (RBC) and platelet (PLT) param...
BACKGROUND: Progression-free survival (PFS) is a critical end point in oncology, yet real-world appl...